Free Trial

P3 Health Partners (NASDAQ:PIII) Reaches New 1-Year Low - Time to Sell?

P3 Health Partners logo with Medical background

P3 Health Partners Inc. (NASDAQ:PIII - Get Free Report)'s stock price reached a new 52-week low on Tuesday . The stock traded as low as $7.00 and last traded at $8.99, with a volume of 81115 shares changing hands. The stock had previously closed at $7.58.

P3 Health Partners Price Performance

The company's 50 day moving average is $9.32 and its 200-day moving average is $11.98. The firm has a market capitalization of $66.36 million, a price-to-earnings ratio of -11.00 and a beta of 0.96. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 1.11.

P3 Health Partners (NASDAQ:PIII - Get Free Report) last released its earnings results on Thursday, March 27th. The company reported ($16.00) earnings per share (EPS) for the quarter, missing the consensus estimate of ($8.50) by ($7.50). P3 Health Partners had a negative return on equity of 71.31% and a negative net margin of 6.95%. The company had revenue of $370.69 million for the quarter, compared to analyst estimates of $378.88 million. Equities research analysts anticipate that P3 Health Partners Inc. will post -0.67 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in PIII. Wealthedge Investment Advisors LLC purchased a new position in P3 Health Partners in the 4th quarter worth approximately $83,000. XTX Topco Ltd purchased a new stake in P3 Health Partners in the fourth quarter worth $46,000. Warberg Asset Management LLC lifted its holdings in shares of P3 Health Partners by 1,353.5% during the fourth quarter. Warberg Asset Management LLC now owns 145,346 shares of the company's stock valued at $33,000 after purchasing an additional 135,346 shares during the last quarter. Sanders Morris Harris LLC grew its stake in shares of P3 Health Partners by 50.0% in the fourth quarter. Sanders Morris Harris LLC now owns 184,497 shares of the company's stock worth $41,000 after acquiring an additional 61,499 shares during the last quarter. Finally, Trinity Financial Advisors LLC bought a new stake in shares of P3 Health Partners during the 4th quarter valued at $261,000. 7.75% of the stock is currently owned by institutional investors and hedge funds.

P3 Health Partners Company Profile

(Get Free Report)

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.

Read More

Should You Invest $1,000 in P3 Health Partners Right Now?

Before you consider P3 Health Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and P3 Health Partners wasn't on the list.

While P3 Health Partners currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines